The biochemistry — NAD and NADP universal redox coenzymes
Niacin is converted in canine tissues to two universal redox coenzymes: NAD (nicotinamide adenine dinucleotide) and NADP (NAD with an additional phosphate). Per standard biochemistry references, NAD and NADP serve as electron carriers in hundreds of enzymatic reactions across carbohydrate, fat, and amino acid metabolism, including glycolysis (glyceraldehyde-3-phosphate dehydrogenase), the citric acid cycle (isocitrate dehydrogenase, alpha-ketoglutarate dehydrogenase, malate dehydrogenase), beta-oxidation of fatty acids (3-hydroxyacyl-CoA dehydrogenase), the pentose phosphate pathway (glucose-6-phosphate dehydrogenase), and amino acid catabolism (glutamate dehydrogenase).
NAD also serves non-redox functions as a substrate for sirtuins (NAD-dependent protein deacetylases involved in chromatin regulation and metabolic signaling), poly-ADP-ribose polymerases (PARPs, involved in DNA damage response), and cyclic ADP-ribose synthases (calcium signaling). The breadth of NAD- and NADP-dependent enzymes explains why niacin deficiency produces such diverse clinical manifestations — the ‘three Ds’ of human pellagra (dermatitis, diarrhea, dementia) reflect impairment of metabolic and signaling functions across multiple organ systems. In dogs, niacin deficiency historically produced ‘black tongue’ (necrotic ulceration of the oral cavity) before AAFCO-era pet food formulation eliminated clinical deficiency. See our cobalamin (B12) explainer for a B-vitamin with similarly broad but distinct metabolic functions.
Tryptophan-to-niacin conversion — the dog-cat physiology difference
Per Carvalho 1971 (J Nutr) classical canine vitamin B3 biochemistry study and the broader kynurenine-pathway literature, dogs can synthesize limited niacin from the essential amino acid tryptophan via the kynurenine pathway. The pathway proceeds through several intermediates (kynurenine, 3-hydroxykynurenine, 3-hydroxyanthranilic acid, quinolinic acid) before reaching nicotinic acid mononucleotide and entering the NAD biosynthetic pathway. The dietary conversion efficiency in dogs is approximately 60 mg tryptophan to 1 mg niacin equivalent — sufficient to contribute meaningfully to niacin status but insufficient to meet the AAFCO 2024 minimum requirement on tryptophan alone.
Cats have a markedly different physiology. Per AAFP 2024 Feline Feeding Guidelines and the AAFCO 2024 cat food nutrient profiles, cats lack functional tryptophan-to-niacin conversion entirely (the picolinic acid carboxylase enzyme is absent in feline tissues), making dietary niacin an absolute requirement. The AAFCO 2024 cat food nutrient profiles specify niacin minimum at 60 mg/kg dry matter — approximately 4× the canine minimum — reflecting the absence of the tryptophan-conversion contribution. This dog-vs-cat physiological difference is one of several that justify separate dog and cat nutrient profiles per AAFCO 2024 framework. Owners should not feed cats dog food long-term in part for this reason. See our taurine explainer for another well-known dog-vs-cat physiological difference relevant to species-specific formulation.
AAFCO 2024 nutrient profile — 13.6 mg/kg DM minimum
Per AAFCO 2024 Official Publication dog food nutrient profiles, the niacin minimum is 13.6 mg/kg dry matter for adult maintenance and growth/reproduction. No maximum is specified, reflecting that canine niacin toxicity from dietary sources is rare. Per NRC 2006, single-dose niacin toxicity in dogs has been described at doses above approximately 1,000 mg/kg body weight, far above any typical dietary or supplemental exposure. The substantial safety margin between requirement and toxicity makes niacin one of the safer B-vitamins for over-supplementation, though chronic high-dose niacin supplementation outside veterinary direction is not recommended.
AAFCO-compliant commercial dog foods meet the niacin requirement uniformly. Meat ingredients (beef liver, poultry liver, fish, muscle meats) carry substantial niacin content per USDA FoodData Central reference values, and pet food formulations typically supplement with niacin or niacinamide as part of the vitamin premix to ensure end-of-shelf-life compliance with AAFCO 2024 minimums even after storage losses. The practical implication is that owners do not need to track niacin separately — the AAFCO-compliant formulation covers it. See our choline explainer and biotin explainer for the broader B-vitamin family context.
Niacin vs niacinamide — functionally equivalent for dogs
Per AAFCO 2024 Official Publication ingredient definitions, both niacin (nicotinic acid) and niacinamide (nicotinamide) have full regulatory clearance and either may appear on commercial pet food labels. The two forms are converted to NAD and NADP via the same Preiss-Handler pathway in canine tissues and serve identical vitamin function at AAFCO-compliant dietary doses. The two forms differ only at pharmacologic doses (orders of magnitude above the AAFCO minimum), where niacin produces vasodilatory flushing (mediated by GPR109A receptor activation) and lowers blood lipid levels (used in human cardiology), while niacinamide does not produce these effects.
For canine vitamin function at AAFCO-compliant dietary doses, the two forms are interchangeable. Niacinamide is somewhat more commonly used in pet food vitamin premixes because it is more stable under processing and storage conditions and does not produce the flushing reaction at any practical dietary dose — making it the default formulator choice. Label declarations may use either name; both meet the AAFCO 2024 niacin minimum requirement.
How KibbleIQ scores niacin
The KibbleIQ Dry Kibble Rubric treats niacin as a baseline AAFCO-compliance requirement. All AAFCO-compliant complete dog foods meet the 13.6 mg/kg DM minimum by default through a combination of meat-ingredient natural niacin content and targeted niacin or niacinamide premix supplementation. The rubric does not award additional credit for niacin presence above the AAFCO minimum because niacin is not a clinical-outcome-distinguishing nutrient at standard dietary ranges.
Niacin is not a tracked-supplement nutrient in the way that EPA + DHA, glucosamine, or taurine are. The clinical-decision framework for owners is that niacin status is uniformly met by AAFCO-compliant commercial feeding, and intentional niacin supplementation outside veterinary direction is unnecessary in healthy dogs. The relevance to the rubric is mostly category-defining: niacin presence on a label confirms the formulator addressed the AAFCO 2024 vitamin-premix requirements; absence would be a red flag for non-compliance. See our AAFCO statement explainer for the broader regulatory-compliance framework. To check whether your dog’s food carries the expected B-vitamin premix declarations, paste the ingredient list into the KibbleIQ analyzer.